Feb. 9 Quick Takes: First-day bump for Adagene; plus Drug Farm, Taysha, Nuance-Antibe, CMS-Luqa and more

Suzhou, China-based Adagene Inc. (NASDAQ:ADAG) gained $10.99 (58%) to $29.99 after raising $140 million in a bumped-up IPO through the sale of 7.3 million ADSs at $19. The company has clinical mAbs targeting 4-1BB and CTLA-4.

Drug Farm raises $56M 
China- and U.S.-based Drug Farm raised $56 million to begin clinical testing of DF-006 to treat hepatitis B virus (HBV) infection and other liver diseases. Investors include BioVeda China Fund, the WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359) corporate venture fund, South China Venture Capital, Detong Capital and Zhejiang United Investment Group. ...